ArticleSchizophrenia bulletin2025
The Philadelphia Neurodevelopmental Cohort: Perspective, Lessons, and Future Directions.
Article in Schizophrenia bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychiatric Antecedents in Adolescents at Clinical High Risk for Psychosis: Insights from the "Parma At-Risk Mental States" Follow-up Program.Research on child and adolescent psychopathology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The Philadelphia Neurodevelopmental Cohort (PNC), a response to an NIMH request for applications to stimulate the economy has mobilized Penn-CHOP investigators to rise to this Grand Opportunity and do what seemed to be unthinkable. In a 2-year period (2009-2011), we established and trained research teams, conducted an in-person assessment of psychopathology, and administered a computerized neurocognitive battery to about 10,000 genotyped youth ages 8-21, with a subsample of about 1600 undergoing multimodal neuroimaging. Over a decade later, with the field moving forward to large-scale collaborative projects, and us building on the PNC in longitudinal studies, we provide a perspective on the rationale that guided our decisions, the tools, and procedures developed for the implementation of data collection, the rigorous process of ensuring high data quality, and data sharing. We highlight the experience and lessons learned: What could we have done better or differently? We feature the importance of access to electronic health records, gaining a developmental perspective, and sample diversity. Given our interest in the psychosis spectrum (PS), special emphasis will relate to multimodal measurements of youths with PS features. In this issue, we present some key PNC findings, that relate to brain development and PS, highlighted within the context of reported findings from other studies in community-based cohorts, help-seeking youth at risk for psychosis, and those early in the course of schizophrenia spectrum disorders. Building on the PNC, we summarize future opportunities for longitudinal and intergenerational investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.